PortfoliosLab logo

Fate Therapeutics, Inc.

FATE
Equity · Currency in USD
Sector
Healthcare
Industry
Biotechnology
ISIN
US31189P1021
CUSIP
31189P102

FATEPrice Chart


Chart placeholderClick Calculate to get results

FATEPerformance

The chart shows the growth of $10,000 invested in Fate Therapeutics, Inc. on Oct 2, 2013 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $89,124 for a total return of roughly 791.24%. All prices are adjusted for splits and dividends.


FATE (Fate Therapeutics, Inc.)
Benchmark (S&P 500)

FATEReturns in periods

Returns over 1 year are annualized

PeriodReturn
1M-13.40%
6M-29.95%
YTD-35.11%
1Y32.70%
5Y90.14%
10Y31.20%

FATEMonthly Returns Heatmap


Chart placeholderClick Calculate to get results

FATESharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Fate Therapeutics, Inc. Sharpe ratio is 0.29. A Sharpe ratio between 0 and 1.0 is considered sub-optimal.

The chart below displays rolling 12-month Sharpe Ratio.


FATE (Fate Therapeutics, Inc.)
Benchmark (S&P 500)

FATEDividends


Fate Therapeutics, Inc. doesn't pay dividends

FATEDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


FATE (Fate Therapeutics, Inc.)
Benchmark (S&P 500)

FATEWorst Drawdowns

The table below shows the maximum drawdowns of the Fate Therapeutics, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Fate Therapeutics, Inc. is 87.87%, recorded on May 19, 2016. It took 449 trading sessions for the portfolio to recover.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-87.87%Mar 27, 2014542May 19, 2016449Mar 2, 2018991
-53.21%Jan 15, 2021185Oct 8, 2021
-45.8%Feb 27, 202013Mar 16, 202047May 21, 202060
-45.76%Oct 8, 201324Nov 8, 201376Mar 3, 2014100
-40.49%Jul 29, 201972Nov 6, 201946Jan 14, 2020118
-36.46%Mar 6, 2018102Jul 30, 201837Sep 20, 2018139
-32.27%Dec 6, 201812Dec 21, 201810Jan 8, 201922
-30.17%Oct 3, 201816Oct 24, 201827Dec 3, 201843
-24.22%Jan 11, 201919Feb 7, 201923Mar 13, 201942
-20.89%May 29, 201910Jun 11, 201912Jun 27, 201922

FATEVolatility Chart

Current Fate Therapeutics, Inc. volatility is 41.07%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


FATE (Fate Therapeutics, Inc.)
Benchmark (S&P 500)

Portfolios with Fate Therapeutics, Inc.


Loading data...

More Tools for Fate Therapeutics, Inc.